Skip to content

Pulsar-18 5/150/90Recalls & reported problems

Biotronik AG · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07640130436169), received between Oct 8, 2020 and Oct 13, 2020 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Positioning Failure” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Positioning Failure2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 13, 2020Positioning Failure; Positioning Failure

    THE PULSAR-18 STENT SYSTEM WAS CHOSEN FOR THE TREATMENT OF A SEVERELY CALCIFIED LESION IN THE SFA BUT THE STENT COULD NOT BE RELEASED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10670599 ↗
  • MalfunctionOct 8, 2020Positioning Failure; Positioning Failure

    THE PULSAR-18 STENT SYSTEM WAS CHOSEN FOR THE TREATMENT OF A CALCIFIED LAND TORTUOUS LESION IN THE SFA. DURING THE ATTEMPT TO DEPLOY THE STENT IT WAS NOT POSSIBLE TO RELEASE IT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10649633 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page